0001209191-23-011245.txt : 20230221 0001209191-23-011245.hdr.sgml : 20230221 20230221165808 ACCESSION NUMBER: 0001209191-23-011245 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230221 DATE AS OF CHANGE: 20230221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Millar Kerri-Ann CENTRAL INDEX KEY: 0001739126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 23649177 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-16 0 0001645460 Cue Biopharma, Inc. CUE 0001739126 Millar Kerri-Ann C/O CUE BIOPHARMA INC. 40 GUEST STREET BOSTON MA 02135 0 1 0 0 CHIEF FINANCIAL OFFICER Stock Option (right to buy) 3.21 2023-02-16 4 A 0 124000 0.00 A 2033-02-15 Common Stock 124000 124000 D This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023. /s/ Kerri-Ann Millar by Colin Sandercock, attorney-in-fact 2023-02-21